You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immuno therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burnout, Professional Trial in Semarang (Traditional Music Therapy)

Not yet recruiting
  • Burnout, Professional
  • Traditional Music Therapy
  • Semarang, Jawa Tengah, Indonesia
    RSUP dr. Kariadi Semarang
Nov 12, 2023

Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • toripalimab FOLFOX
  • (no location specified)
Aug 3, 2023

NSCLC, Non-Small-Cell Lung Carcinoma, Circulating Tumor DNA Trial (biological, drug, other)

Withdrawn
  • Non-Small Cell Lung Cancer
  • +2 more
  • Nivolumab
  • +8 more
  • (no location specified)
Mar 9, 2022

Acute Respiratory Distress Syndrome, Covid19 Trial in Ottawa (Mesenchymal Stromal Cells)

Completed
  • Acute Respiratory Distress Syndrome
  • Covid19
  • Mesenchymal Stromal Cells
  • Ottawa, Ontario, Canada
    The Ottawa Hospital
Apr 23, 2021

Fibromyalgia Trial in Barcelona (TAU + FIBRO-On, TAU + FIBRO-Out, Treatment as Usual (TAU))

Not yet recruiting
  • Fibromyalgia
  • TAU + FIBRO-On
  • +2 more
  • Barcelona, Spain
    Hospital Vall Hebron
Jul 27, 2022

Covid19, Acute Respiratory Distress Syndrome Trial in Canada (UC-MSCs, Placebo)

Recruiting
  • Covid19
  • Acute Respiratory Distress Syndrome
  • UC-MSCs
  • Placebo
  • Oshawa, Ontario, Canada
  • +3 more
May 4, 2021

Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

Not yet recruiting
  • Human Immuno-deficiency Virus (HIV) Disease
  • (no location specified)
Sep 5, 2023

Obesity Trial in Campinas (shock wave therapy)

Completed
  • Obesity
  • shock wave therapy
  • Campinas, SP, Brazil
    Unicamp
Aug 17, 2021

HIV Trial in Stanford (Ritonavir, gp160 Vaccine (Immuno-AG), Stavudine)

Completed
  • HIV Infections
  • Stanford, California
    Stanford CRS
Oct 27, 2021

Learn About First and Later Lines of Medicines in Treating

Completed
  • Metastatic Renal Cell Carcinoma
    • New York, New York
      Pfizer Headquarters
    May 12, 2023

    Cabozantinib Post First-line Immuno-oncology Checkpoint

    Completed
    • Advanced Renal Cell Carcinoma (aRCC)
      • Glasgow, United Kingdom
      • +8 more
      Jun 30, 2022

      High-Risk Cancer, Locally Advanced Breast Cancer Trial in London (Neoadjuvant radiotherapy)

      Recruiting
      • High-Risk Cancer
      • Locally Advanced Breast Cancer
      • Neoadjuvant radiotherapy
      • London, Ontario, Canada
        London Regional Cancer Program
      Aug 11, 2021

      Urine Omics Predicting IO Therapy Responses in mRCC Patients

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • No intervention required
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jan 18, 2022

      Non Small Cell Lung Cancer Metastatic Trial in Morgantown (Radiation, Immuno-Therapeutic Agent)

      Active, not recruiting
      • Non Small Cell Lung Cancer Metastatic
      • Radiation
      • Immuno-Therapeutic Agent
      • Morgantown, West Virginia
        WVU Cancer Institute - Mary Babb Randolph Cancer Center
      Apr 25, 2022

      Urine Omics Predicting IO Therapy Responses in mUC Patients

      Recruiting
      • Metastatic Urothelial Carcinoma
      • No intervention required
      • Taipei, Taiwan
        National Taiwan University Hospital
      Dec 19, 2021

      Acute Lymphoblastic Leukemia, Pediatric, ALL, Infants Trial (the risk-adapted choice of therapy and the use of a combination of

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, Pediatric
      • ALL, Infants
      • the risk-adapted choice of therapy and the use of a combination of chemotherapy with immunotherapy and hematopoietic stem cell transplantation for patients with risk factors.
      • (no location specified)
      Aug 26, 2021

      Cancer Trial in Chicago (Nivolumab, Cabiralizumab, Urelumab)

      Active, not recruiting
      • Cancer
      • Chicago, Illinois
        University of Chicago Medical Center
      Mar 14, 2022

      Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma Grade 3A Trial in Italy (OFATUMUMAB)

      Completed
      • Follicular Lymphoma, Grade 1
      • +2 more
      • Alessandria, AL, Italy
      • +26 more
      Jun 16, 2022

      Metastatic Melanoma Trial in Worldwide (LGX818, MEK162, Nivolumab)

      Active, not recruiting
      • Metastatic Melanoma
      • Salzburg, AT, Austria
      • +29 more
      Feb 23, 2022

      Malignant Solid Tumor Trial in Worldwide (BMS-986179, Nivolumab, rHuPH20)

      Completed
      • Malignant Solid Tumor
      • BMS-986179
      • +2 more
      • Chicago, Illinois
      • +23 more
      May 25, 2022

      Solid Tumor, Adult Trial in United States (IMSA101, Immune checkpoint inhibitor (ICI), Immuno-oncology (IO) therapy)

      Recruiting
      • Solid Tumor, Adult
      • Scottsdale, Arizona
      • +5 more
      Apr 14, 2022

      Cancer Trial in Sioux Falls, Ottawa, Toronto (BMS-986277, Nivolumab)

      Terminated
      Has Results
      • Cancer
      • BMS-986277
      • Nivolumab
      • Sioux Falls, South Dakota
      • +2 more
      Nov 20, 2020

      Advanced Cancer Trial in Worldwide (BMS-986178, Nivolumab, Ipilimumab)

      Completed
      Has Results
      • Advanced Cancer
      • Aurora, Colorado
      • +21 more
      Dec 25, 2021

      Plasmodium Falciparum Trial in Kisumu (RTS,S/AS01E, Abhayrab rabies vaccine)

      Active, not recruiting
      • Plasmodium Falciparum
      • RTS,S/AS01E
      • Abhayrab rabies vaccine
      • Kisumu, Kisumu County, Kenya
        Kombewa Clinical Research Center
      Oct 7, 2021

      ApricityRx™ for Management of IR-AEs in Patients on

      Recruiting
      • Cancer
      • ApricityRx mobile application
      • New York, New York
        Columbia University Irving Medical Center
      Sep 25, 2020